These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3162228)

  • 1. Linkage of a polymorphic marker for the type III collagen gene (COL3A1) to atypical autosomal dominant Ehlers-Danlos syndrome type IV in a large Belgian pedigree.
    Nicholls AC; De Paepe A; Narcisi P; Dalgleish R; De Keyser F; Matton M; Pope FM
    Hum Genet; 1988 Mar; 78(3):276-81. PubMed ID: 3162228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen.
    Tsipouras P; Byers PH; Schwartz RC; Chu ML; Weil D; Pepe G; Cassidy SB; Ramirez F
    Hum Genet; 1986 Sep; 74(1):41-6. PubMed ID: 2875936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
    Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
    Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exclusion of COL1A1, COL1A2, and COL3A1 genes as candidate genes for Ehlers-Danlos syndrome type I in one large family.
    Sokolov BP; Prytkov AN; Tromp G; Knowlton RG; Prockop DJ
    Hum Genet; 1991 Dec; 88(2):125-9. PubMed ID: 1684560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ehlers-Danlos syndrome type IV is associated with a novel G984R COL3A1 mutation.
    Deng Y; Wei S; Hu S; Chen J; Tan Z; Yang Y
    Mol Med Rep; 2015 Jul; 12(1):1119-24. PubMed ID: 25776230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage of the gene that encodes the alpha 1 chain of type V collagen (COL5A1) to type II Ehlers-Danlos syndrome (EDS II).
    Loughlin J; Irven C; Hardwick LJ; Butcher S; Walsh S; Wordsworth P; Sykes B
    Hum Mol Genet; 1995 Sep; 4(9):1649-51. PubMed ID: 8541855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a large deletion associated with a polymorphic block of repeated dinucleotides in the type III procollagen gene (COL3A1) of a patient with Ehlers-Danlos syndrome type IV.
    Lee B; D'Alessio M; Vissing H; Ramirez F; Steinmann B; Superti-Furga A
    Am J Hum Genet; 1991 Mar; 48(3):511-7. PubMed ID: 1998337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segregation analysis of the structural genes of the major fibrillar collagens provides further evidence of molecular heterogeneity in type II Ehlers-Danlos syndrome.
    Wordsworth BP; Ogilvie DJ; Sykes BC
    Br J Rheumatol; 1991 Jun; 30(3):173-7. PubMed ID: 2049575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II.
    Burrows NP; Nicholls AC; Yates JR; Gatward G; Sarathachandra P; Richards A; Pope FM
    J Invest Dermatol; 1996 Jun; 106(6):1273-6. PubMed ID: 8752669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic linkage to the collagen alpha 1 (V) gene (COL5A1) in two British Ehlers-Danlos syndrome families with variable type I and II phenotypes.
    Burrows NP; Nicholls AC; Yates JR; Richards AJ; Pope FM
    Clin Exp Dermatol; 1997 Jul; 22(4):174-6. PubMed ID: 9499606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Ehlers-Danlos and Marfan syndromes in young children].
    De Paepe A; Van den Bossche H; Mortier G; Matton M
    J Genet Hum; 1988 Jun; 36(3):247-53. PubMed ID: 3411305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exclusion of the alpha 1(II) collagen structural gene as the mutant locus in type II Ehlers-Danlos syndrome.
    Wordsworth P; Ogilvie D; Smith R; Sykes B
    Ann Rheum Dis; 1985 Jul; 44(7):431-3. PubMed ID: 2992397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.
    Chiodo AA; Sillence DO; Cole WG; Bateman JF
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):939-43. PubMed ID: 7487954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ehlers-Danlos syndrome type IV with few extrathoracic findings: a newly recognized point mutation in the COL3A1 gene.
    Watanabe A; Kawabata Y; Okada O; Tanabe N; Kimura H; Hatamochi A; Shinkai H; Sakai N; Shimada T; Hiroshima K; Kuriyama T
    Eur Respir J; 2002 Jan; 19(1):195-8. PubMed ID: 11843319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen.
    Narcisi P; Richards AJ; Ferguson SD; Pope FM
    Hum Mol Genet; 1994 Sep; 3(9):1617-20. PubMed ID: 7833919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ehlers-Danlos specter revisited.
    Cikrit DF; Glover JR; Dalsing MC; Silver D
    Vasc Endovascular Surg; 2002; 36(3):213-7. PubMed ID: 12075387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 27-bp deletion from one allele of the type III collagen gene (COL3A1) in a large family with Ehlers-Danlos syndrome type IV.
    Richards AJ; Lloyd JC; Narcisi P; Ward PN; Nicholls AC; De Paepe A; Pope FM
    Hum Genet; 1992 Jan; 88(3):325-30. PubMed ID: 1370809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families.
    Burrows NP; Nicholls AC; Richards AJ; Luccarini C; Harrison JB; Yates JR; Pope FM
    Am J Hum Genet; 1998 Aug; 63(2):390-8. PubMed ID: 9683580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ehlers-Danlos syndrome type IV: phenotypic consequences of a splicing mutation in one COL3A1 allele.
    Sillence DO; Chiodo AA; Campbell PE; Cole WG
    J Med Genet; 1991 Dec; 28(12):840-5. PubMed ID: 1757960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal extracellular matrix in Ehlers-Danlos syndrome type IV due to the substitution of glycine 934 by glutamic acid in the triple helical domain of type III collagen.
    McGrory J; Weksberg R; Thorner P; Cole WG
    Clin Genet; 1996 Dec; 50(6):442-5. PubMed ID: 9147870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.